EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2024 -5.040
March 31, 2024 -4.767
December 31, 2023 -6.514
September 30, 2023 -9.949
June 30, 2023 -15.42
March 31, 2023 -18.16
December 31, 2022 -16.03
September 30, 2022 -17.00
June 30, 2022 -16.86
March 31, 2022 -16.35
December 31, 2021 -14.65
September 30, 2021 -11.81
June 30, 2021 -15.24
March 31, 2021 -14.31
December 31, 2020 -19.02
September 30, 2020 -20.88
June 30, 2020 -22.02
March 31, 2020 -50.91
December 31, 2019 -288.53
September 30, 2019 -151.99
June 30, 2019 -143.76
March 31, 2019 -206.56
December 31, 2018 -178.30
September 30, 2018 -252.98
June 30, 2018 -229.92
Date Value
March 31, 2018 -226.87
December 31, 2017 -945.47
September 30, 2017 -566.40
June 30, 2017 -921.60
March 31, 2017 -672.00
December 31, 2016 -672.00
September 30, 2016 -2001.02
June 30, 2016 -11040.00
March 31, 2016 -2304.00
December 31, 2015 -2080.51
September 30, 2015 -2080.90
June 30, 2015 -2496.00
March 31, 2015 -2304.00
December 31, 2014 -2880.00
September 30, 2014 -8064.00
June 30, 2014 -12096.00
March 31, 2014 -13248.00
December 31, 2013 -14370.62
September 30, 2013 -12096.00
June 30, 2013 -13248.00
March 31, 2013 -11520.00
December 31, 2012 -16128.00
September 30, 2012 -13248.00
June 30, 2012 -13248.00
March 31, 2012 48384.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
Anika Therapeutics, Inc. 0.2412
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412